These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9649131)
21. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766 [TBL] [Abstract][Full Text] [Related]
22. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816 [TBL] [Abstract][Full Text] [Related]
23. Extended lifespan and immortalization of human fibroblasts induced by X-ray irradiation. Tsutsui T; Tanaka Y; Matsudo Y; Hasegawa K; Fujino T; Kodama S; Barrett JC Mol Carcinog; 1997 Jan; 18(1):7-18. PubMed ID: 9022808 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations. Ponti F; Corsini S; Gnoli M; Pedrini E; Mordenti M; Sangiorgi L Fam Cancer; 2016 Oct; 15(4):635-43. PubMed ID: 26956143 [TBL] [Abstract][Full Text] [Related]
25. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Frebourg T; Barbier N; Yan YX; Garber JE; Dreyfus M; Fraumeni J; Li FP; Friend SH Am J Hum Genet; 1995 Mar; 56(3):608-15. PubMed ID: 7887414 [TBL] [Abstract][Full Text] [Related]
26. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Varley JM; Thorncroft M; McGown G; Appleby J; Kelsey AM; Tricker KJ; Evans DG; Birch JM Oncogene; 1997 Feb; 14(7):865-71. PubMed ID: 9047394 [TBL] [Abstract][Full Text] [Related]
27. Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations. Barley RD; Enns L; Paterson MC; Mirzayans R Oncogene; 1998 Aug; 17(5):533-43. PubMed ID: 9704919 [TBL] [Abstract][Full Text] [Related]
28. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome. Macedo GS; Araujo Vieira I; Brandalize AP; Giacomazzi J; Inez Palmero E; Volc S; Rodrigues Paixão-Côrtes V; Caleffi M; Silva Alves M; Achatz MI; Hainaut P; Ashton-Prolla P Cancer Genet; 2016 Mar; 209(3):97-106. PubMed ID: 26823150 [TBL] [Abstract][Full Text] [Related]
29. Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage. Zerdoumi Y; Lanos R; Raad S; Flaman JM; Bougeard G; Frebourg T; Tournier I Hum Mol Genet; 2017 Jul; 26(14):2591-2602. PubMed ID: 28369373 [TBL] [Abstract][Full Text] [Related]
31. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Villani A; Tabori U; Schiffman J; Shlien A; Beyene J; Druker H; Novokmet A; Finlay J; Malkin D Lancet Oncol; 2011 Jun; 12(6):559-67. PubMed ID: 21601526 [TBL] [Abstract][Full Text] [Related]
32. Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation. Yamazaki F; Shima H; Osumi T; Narumi S; Kuroda T; Shimada H J Pediatr Hematol Oncol; 2018 Apr; 40(3):e195-e197. PubMed ID: 28902083 [TBL] [Abstract][Full Text] [Related]
33. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
34. Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome. Buzby JS; Williams SA; Schaffer L; Head SR; Nugent DJ Cancer Genet; 2017 Feb; 211():9-17. PubMed ID: 28279309 [TBL] [Abstract][Full Text] [Related]
35. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S; JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041 [TBL] [Abstract][Full Text] [Related]
36. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Bougeard G; Brugières L; Chompret A; Gesta P; Charbonnier F; Valent A; Martin C; Raux G; Feunteun J; Bressac-de Paillerets B; Frébourg T Oncogene; 2003 Feb; 22(6):840-6. PubMed ID: 12584563 [TBL] [Abstract][Full Text] [Related]
37. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. Sherif ZA; Danielsen M Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121 [TBL] [Abstract][Full Text] [Related]
38. The Li-Fraumeni syndrome. Chompret A Biochimie; 2002 Jan; 84(1):75-82. PubMed ID: 11900879 [TBL] [Abstract][Full Text] [Related]
39. The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes. Ruijs MW; Schmidt MK; Nevanlinna H; Tommiska J; Aittomäki K; Pruntel R; Verhoef S; Van't Veer LJ Eur J Hum Genet; 2007 Jan; 15(1):110-4. PubMed ID: 17003841 [TBL] [Abstract][Full Text] [Related]
40. Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Varley JM; Chapman P; McGown G; Thorncroft M; White GR; Greaves MJ; Scott D; Spreadborough A; Tricker KJ; Birch JM; Evans DG; Reddel R; Camplejohn RS; Burn J; Boyle JM Oncogene; 1998 Jun; 16(25):3291-8. PubMed ID: 9681828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]